Strategies for successful management of older patients with seizures

Geriatrics

Volumn 54, Issue 12, 1999, Pages 31-46

  Eisenschenk, Stephan ^a   Gilmore, Robin ^a  

^a UNIVERSITY OF FLORIDA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ANTACID AGENT; ANTICONVULSIVE AGENT; CARBAMAZEPINE; CHLORPROMAZINE; CIMETIDINE; CYCLOSPORIN; DEXTROPROPOXYPHENE; DIGOXIN; DILTIAZEM; ERYTHROMYCIN; GABAPENTIN; GABATRIL; HALOPERIDOL; IMIPRAMINE; ISONIAZID; LAMOTRIGINE; PHENYTOIN; SULFANILAMIDE DERIVATIVE; THEOPHYLLINE; TIAGABINE; TOPIRAMATE; UNCLASSIFIED DRUG; VALPROATE SEMISODIUM; VALPROIC ACID; VERAPAMIL; WARFARIN;

AGED; ATAXIA; COGNITIVE DEFECT; DRUG ABSORPTION; DRUG EFFICACY; DRUG HALF LIFE; DRUG SAFETY; EPILEPSY; GERIATRIC CARE; HUMAN; PATIENT COMPLIANCE; PRACTICE GUIDELINE; PRESCRIPTION; PROGNOSIS; REVIEW; SEIZURE; STEVENS JOHNSON SYNDROME;

AGE DISTRIBUTION; AGE FACTORS; AGED; AGING; ALGORITHMS; ANTICONVULSANTS; DECISION TREES; DISEASE MANAGEMENT; DRUG INTERACTIONS; DRUG MONITORING; EPILEPSY; HUMANS; MIDDLE AGED; PATIENT SELECTION; PRACTICE GUIDELINES; PROGNOSIS;

EID: 0032716005     PISSN: 0016867X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (19)

1. Hauser WA, Kurland LT: Incidence of epilepsy and unprovoked seizures in Rochester, Minnesota: 1935-1984. Epilepsia 1993; 34(3):453-68.
2. Eisenschenk S, Gilmore R. Seizures: Etiologies and differential diagnosis in older patients. Geriatrics 1999; 54(Nov): 18-30.
3. Wallace SM, Verbeeck RK. Plasma protein binding of drugs in the elderly. Clin Pharmacokinet 1987; 12(1):41-72.
4. Wynne HA, Cope LH, Mutch E, Rawlins MD, Woodhouse KW, James OF. The effect of age on liver volume and apparent liver blood flow in healthy man. Hepatology 1989; 2:297-301.
5. Dawling S, Crome P. Clinical pharmacokinetic considerations in the elderly: An update. Clin Pharmacokinet 1989; 17(4):236-63.
6. Mattson RH, Cramer JA, Collins JF, et al. Comparison of carbamazepine, phenobarbital, phenytoin, and primidone in partial and secondarily generalized tonic-clonic seizures. N Engl J Med 1985; 313(3):145-51.
7. Mattson RH, Cramer JA, Collins JF, et al. A comparison of valproate with carbamazepine for the treatment of complex partial seizures and secondarily generalized tonic-clonic seizures in adults. N Engl J Med 1992; 327(11):765-71.
8. Durelli L, Mutani R, Sechi GP, Monaco F, Glorioso N, Gusmaroli G. Cardiac side-effects of phenytoin and carbamazepine. A dose related phenomenon? Arch Neurol 1985; 42(11):1067-8.
9. Cohen J, Scheuer ML. Antiepileptic drug use in elderly patients with epilepsy. Epilepsia 1991; 32(suppl 3):53.
10. Hayes MJ, Langman MJ, Short AH. Changes in drug metabolism with increasing age: 2. Phenytoin clearance and protein binding. Br J Clin Pharmacol 1975; 2(1):73-9.
11. Gabapentin as add-on therapy in refractory partial epilepsy: A double-blind, placebo-controlled, parallel-group study. The US Gabapentin Study Group No. 5. Neurology 1993; 43(11):2292-8.
12. Andrews CO, Fischer JH. Gabapentin: A new agent for the management of epilepsy. Ann Pharmacother 1994; 28(10):1188-96.
13. Goa KL, Ross SR, Chrisp P. Lamotrigine. A review of its pharmacological properties and clinical efficacy in epilepsy. Drugs 1993; 46(1):152-76.
14. Binnie CD, Debets RM, Engelsman M, et al. Double-blind cross-over trial of lamotrigine (Lamictal) as add-on therapy in intractable epilepsy. Epilepsy Res 1989; 4(3):222-9.
15. Pledger G, Reife R, Lim P, Karim R. Overview of topiramate efficacy from adjunctive therapy trials. Epilepsia 1995; 36(suppl 3):S150.
16. Rowan AJ, Uthman B, Ahmann P, et al. Safety and efficacy of three dose levels of tiagabine HCl versus placebo as adjunctive treatment for complex partial seizures: Epilepsia 1994; 35(suppl 8):54.
17. Luhdorf K, Jensen LK, Plesner AM. Epilepsy in the elderly: Prognosis. Acta Scand Neural 1986; 74(5):409-15.
18. Luhdorf K, Jensen LK, Plesner AM. Epilepsy in the elderly: Life-expectancy and causes of death. Acta Neurol Scand 1987; 76(3):183-90.
19. Hunt PA, Wu-Chen ML, Handal NJ, et al. Bone disease induced by anticonvulsant therapy and treatment with calcitriol (1,25-dihydroxyvitamin D3). Am J Dis Child 1986; 140(7):715-22.